[go: up one dir, main page]

FI933728L - Framstaellning och anvaendning av formalin-doedade e.coli-organismer som uttrycker kolonisationfaktorantigen (cfa) foer vaccinering mot tarminflammation/diarre foerorsakad av enterotoxigeniska e.coli bakterier i maenniskan - Google Patents

Framstaellning och anvaendning av formalin-doedade e.coli-organismer som uttrycker kolonisationfaktorantigen (cfa) foer vaccinering mot tarminflammation/diarre foerorsakad av enterotoxigeniska e.coli bakterier i maenniskan Download PDF

Info

Publication number
FI933728L
FI933728L FI933728A FI933728A FI933728L FI 933728 L FI933728 L FI 933728L FI 933728 A FI933728 A FI 933728A FI 933728 A FI933728 A FI 933728A FI 933728 L FI933728 L FI 933728L
Authority
FI
Finland
Prior art keywords
coli
vaccinering
uttrycker
tarminflammation
organismer
Prior art date
Application number
FI933728A
Other languages
English (en)
Other versions
FI933728A0 (fi
FI108775B (fi
Inventor
Jan Holmgrem
Ann-Mari Svennerholm
Original Assignee
Holmgren Jan
Svennerholm Ann Mari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holmgren Jan, Svennerholm Ann Mari filed Critical Holmgren Jan
Publication of FI933728A0 publication Critical patent/FI933728A0/fi
Publication of FI933728L publication Critical patent/FI933728L/fi
Application granted granted Critical
Publication of FI108775B publication Critical patent/FI108775B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI933728A 1991-02-26 1993-08-25 Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi FI108775B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9100556 1991-02-26
SE9100556A SE9100556D0 (sv) 1991-02-26 1991-02-26 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
SE9200110 1992-02-25
PCT/SE1992/000110 WO1992014487A1 (en) 1991-02-26 1992-02-25 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans

Publications (3)

Publication Number Publication Date
FI933728A0 FI933728A0 (fi) 1993-08-25
FI933728L true FI933728L (fi) 1993-10-25
FI108775B FI108775B (fi) 2002-03-28

Family

ID=20381987

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933728A FI108775B (fi) 1991-02-26 1993-08-25 Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi

Country Status (22)

Country Link
US (1) US6558678B1 (fi)
EP (1) EP0573527B1 (fi)
JP (1) JP3169608B2 (fi)
KR (1) KR100221452B1 (fi)
AT (1) ATE170755T1 (fi)
AU (1) AU663864B2 (fi)
BG (1) BG61683B1 (fi)
BR (1) BR9205677A (fi)
CA (1) CA2104877C (fi)
CZ (1) CZ281556B6 (fi)
DE (1) DE69226944T2 (fi)
DK (1) DK0573527T3 (fi)
ES (1) ES2123550T3 (fi)
FI (1) FI108775B (fi)
HU (1) HU213924B (fi)
NO (1) NO307867B1 (fi)
OA (1) OA09865A (fi)
RO (1) RO109819B1 (fi)
RU (1) RU2127121C1 (fi)
SE (1) SE9100556D0 (fi)
SK (1) SK280919B6 (fi)
WO (1) WO1992014487A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118758B1 (en) * 1997-01-24 2006-10-10 The United States Of America As Represented By The Secretary Of The Army Transformed bacteria producing CS6 antigens as vaccines
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria
US7404961B2 (en) 1996-08-02 2008-07-29 The United States Of America As Represented By The Secretary Of The Army Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins
US7094883B1 (en) 1996-08-02 2006-08-22 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
US5994078A (en) * 1997-07-31 1999-11-30 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
SE515285C2 (sv) * 1998-12-18 2001-07-09 Sbl Vaccin Ab Oralt vaccin mot diarré
GB0121998D0 (en) 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
CN101711861A (zh) * 2003-10-31 2010-05-26 不列颠哥伦比亚大学 细菌毒力因子及其用途
EP1981536A4 (en) * 2006-02-01 2012-03-14 Gotovax Ab COLONIZATIONAL FACTOROUS ENTEROTOXIGENIC ESCHERICHIA COLI IN RECOMBINANT BACTERIA
BR112013027845A2 (pt) * 2011-05-18 2017-01-03 Ajinomoto Kk Imunoestimulante, ração, método para produzir um imunoestimulante, e, método para imunoestimulação
US8926980B2 (en) 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
AU2011376755B2 (en) * 2011-09-12 2016-09-29 Scandinavian Biopharma Holding Ab Vaccine for protection against ETEC induced diarrhea comprising dmLT.
CA2846279C (en) * 2011-09-12 2021-05-18 Scandinavian Biopharma Holding Ab Method for increasing etec cs6 antigen presentation on cell surface and products obtainable thereof
RO132299A3 (ro) 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD62894A (fi) *
DE1208038B (de) * 1963-08-01 1965-12-30 Wellcome Found Verfahren zur Herstellung von Impfstoffen gegen Coli-Infektionen
GB1472624A (en) 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4338298A (en) * 1980-04-04 1982-07-06 Endowment And Research Foundation At Montana State University Vaccine for passive immunization against enteric colibacillosis and method of use
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
IL79432A (en) * 1985-07-31 1992-05-25 Univ Leland Stanford Junior Unicellular microorganisms having invasive capability due to exogenous inv gene and vaccines comprising such microorganisms
FI76484C (fi) 1986-02-03 1988-11-10 Osmo Norvasto Kundstol.
JPS6399020A (ja) 1986-06-05 1988-04-30 ベイラ−　カレツジ　オブ　メデイシン ワクチンとその製法
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
CA1339307C (en) * 1988-09-06 1997-08-19 Roy Curtiss, Iii Oral immunization by transgenic plants
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria

Also Published As

Publication number Publication date
HUT67198A (en) 1995-02-28
RO109819B1 (ro) 1995-06-30
BG61683B1 (bg) 1998-03-31
ES2123550T3 (es) 1999-01-16
NO307867B1 (no) 2000-06-13
SK91093A3 (en) 1994-05-11
SE9100556D0 (sv) 1991-02-26
AU663864B2 (en) 1995-10-26
SK280919B6 (sk) 2000-09-12
EP0573527A1 (en) 1993-12-15
JPH06505730A (ja) 1994-06-30
AU1330892A (en) 1992-09-15
BG98070A (bg) 1994-06-30
CZ281556B6 (cs) 1996-11-13
DE69226944D1 (de) 1998-10-15
DE69226944T2 (de) 1999-02-11
ATE170755T1 (de) 1998-09-15
BR9205677A (pt) 1994-05-17
US6558678B1 (en) 2003-05-06
DK0573527T3 (da) 1999-06-07
KR100221452B1 (ko) 1999-09-15
NO933037L (no) 1993-08-25
RU2127121C1 (ru) 1999-03-10
OA09865A (en) 1994-08-15
CZ174293A3 (en) 1994-04-13
CA2104877A1 (en) 1992-08-27
JP3169608B2 (ja) 2001-05-28
EP0573527B1 (en) 1998-09-09
WO1992014487A1 (en) 1992-09-03
HU213924B (en) 1997-11-28
HU9302410D0 (en) 1993-11-29
CA2104877C (en) 2005-10-04
NO933037D0 (no) 1993-08-25
KR930703015A (ko) 1993-11-29
FI933728A0 (fi) 1993-08-25
FI108775B (fi) 2002-03-28

Similar Documents

Publication Publication Date Title
FI921952A0 (fi) Foerfarande foer framstaellning av dialkylenpiperidinofoereningar och enantiomerer daerav anvaendbara som laekemedel.
FI921113A0 (fi) Foerfarande och anordning foer kontroll av pulsbreddsmodulatorns (pwm) omvandlare.
FI925735L (fi) Polymerer och oligomerer av gallsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI934109L (fi) Bensoylguanidiner, foerfarande foer framstaellning av dessa, deras anvaendning som laekemedel och laekemedel innehaollande dessa
FI921183L (fi) Nya bensofusionerade laktamer, som fraemjar frigivning av tillvaexthormon
FI932659L (fi) Gallsyraderivat, foerfaranden foer deras framstaellning och anvaendning avdessa foereningar som laekemedel
FI921182A0 (fi) Velangummi som snabbt hydratiseras.
FI931250L (fi) Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI923558A0 (fi) Tetrahydroindazol-, tetrahydrocyklo -pentapyrazol- och hexahydrocykloheptapyrazolfoereningar och deras anvaendning som inhibitorer av hmg-coa-reduktas.
FI923185A0 (fi) Foerfarande och anordning foer framstaellning av fogloesa band- och traodoeglor och deras anvaendning som kapverktyg i band- och traodsaogar.
FI920271L (fi) Polyamintioler som straolningsskyddande aemnen.
FI931336L (fi) Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk
FI923756A0 (fi) Polyolefinkompositioner som omfattar glycerolmonoestrar av c20-24-fettsyror och daerav framstaellda skumprodukter.
FI925946L (fi) Nya 2-sackarinylmetylaryl- och -aryloxiacetat anvaendbara som inhibitorer foer proteolytiska ensymer, kompositioner innehaollande dessa och anvaendning av dessa
FI922235L (fi) Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar paodet centrala nervsystemet
FI933728L (fi) Framstaellning och anvaendning av formalin-doedade e.coli-organismer som uttrycker kolonisationfaktorantigen (cfa) foer vaccinering mot tarminflammation/diarre foerorsakad av enterotoxigeniska e.coli bakterier i maenniskan
FI920342L (fi) Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav.
FI903739A0 (fi) Nya 5-substituerade-1,3,4-tiadiazoler, foerfarande foer deras framstaellning och deras anvaendning som bekaempningsmedel mot skadeinsekter.
FI920192L (fi) Substituerade 1,2,3,4-tetrahydro -cyklopent/b/indoler, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoler och motsvarande foereningar, mellanprodukter och foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI900045A0 (fi) Proteasfattiga gram-positiva bakterier och anvaendning daerav som vaerdorganism foer framstaellning av rekombinationsprodukter.
FI921596A0 (fi) Tetron- och tietetronsyraderivat och fosfolifas a2 som inhibitorer.
FI921340L (fi) Nya tiazolidinon- och oxazolidinonderivat, deras framstaellning och anvaendning som utvidgare av blodkaerlen
FI913138A0 (fi) Foerfarande foer framstaellning av b -laktamer som innehaoller aminotiazol(iminooxiaettiksyra) aettiksyrasidokedjor och mellanprodukter daerav.
FI915609A (fi) Foerfarande och anordning foer styrning av en m-pulsvaexelriktaranordning som bestaor av en mastervaexelriktare och aotminstone en slavvaexelriktare.
FI922472A0 (fi) Gingerol- och gingerdiolderivat som hypokolesterolemiska och antiaterosklerostiska medel.